These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 8758477)

  • 21. High-frequency transduction (HFT) of resistance to ceftazidime and other antibiotics by a wild-type Pseudomonas aeruginosa phage.
    Blahová J; Králiková K; Krcméry V; Mikovicová A
    Zentralbl Bakteriol; 1999 Apr; 289(2):179-83. PubMed ID: 10360318
    [No Abstract]   [Full Text] [Related]  

  • 22. [Application of a millipore membrane transfer method to the study of the activity of 4 beta-lactams on Pseudomonas aeruginosa].
    Denis C; Lesage D; Delisle-Mizon F; Vergez P; Daguet GL
    Pathol Biol (Paris); 1984 May; 32(5):415-20. PubMed ID: 6429614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro study of antibacterial activity of cefepime (Axepim) against gram negative bacteria: comparison with cephalosporins and other beta-lactams].
    Vachée A; Devalckenaere A; Husson MO; Izard D
    Pathol Biol (Paris); 1996 Feb; 44(2):132-7. PubMed ID: 8761598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of MicroScan WalkAway and Vitek 2 for determination of the susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates to cefepime, cefotaxime and ceftazidime.
    Jang W; Park YJ; Park KG; Yu J
    J Antimicrob Chemother; 2013 Oct; 68(10):2282-5. PubMed ID: 23671215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of ceftazidime on enterobacteria and Pseudomonas producers of beta-lactamases].
    Chabbert YA; Derlot E; Courvalin P
    Pathol Biol (Paris); 1985 Sep; 33(7):758-63. PubMed ID: 3936006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further studies of transferable antibiotic resistance in strains of Pseudomonas aeruginosa from four clinical settings in three countries.
    Blahová J; Hupková-Lesická M; Králiková K; Krcméry V; Kubonová K; Torsová V; Bartoníková N; Schäfer V
    J Chemother; 1998 Jun; 10(3):215-20. PubMed ID: 9669646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo selection of oxacillinase-mediated ceftazidime resistance in Pseudomonas aeruginosa.
    Leotard S; Poirel L; Leblanc PE; Nordmann P
    Microb Drug Resist; 2001; 7(3):273-5. PubMed ID: 11759089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of the activity of beta-lactams against Pseudomonas aeruginosa according to phenotypes of resistance].
    Bert F; Briaud I; Branger C; Lambert-Zechovsky N
    Pathol Biol (Paris); 1996 May; 44(5):329-32. PubMed ID: 8758469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of third generation cephalosporins against Pseudomonas aeruginosa in high risk hospital units.
    Puri J; Revathi G; Kundra P; Talwar V
    Indian J Med Sci; 1996 Jul; 50(7):239-43. PubMed ID: 8979542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fourth-generation cephalosporins: in vitro activity against nosocomial gram-negative bacilli compared with beta-lactam antibiotics and ciprofloxacin.
    Tumah H
    Chemotherapy; 2005 May; 51(2-3):80-5. PubMed ID: 15870501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Pfaller MA; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):63-8. PubMed ID: 16650951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains].
    Aktaş Z; Satana D; Kayacan C; Can B; Gönüllü N; Küçükbasmacı O
    Mikrobiyol Bul; 2012 Jul; 46(3):386-97. PubMed ID: 22951651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa and Burkholderia cepacia group strains and isolates.
    Livermore DM; Mushtaq S; Ge Y; Warner M
    Int J Antimicrob Agents; 2009 Nov; 34(5):402-6. PubMed ID: 19428220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of cefepime and cefpirome compared to other third-generation cephem antibiotics against gram-negative nosocomial pathogens.
    Tumah HN
    Pharmazie; 2004 Nov; 59(11):854-8. PubMed ID: 15587586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ofloxacin, norfloxacin and ceftazidime increase the production of alginate and promote the formation of biofilm of Pseudomonas aeruginosa in vitro.
    Takahashi A; Yomoda S; Ushijima Y; Kobayashi I; Inoue M
    J Antimicrob Chemother; 1995 Oct; 36(4):743-5. PubMed ID: 8591955
    [No Abstract]   [Full Text] [Related]  

  • 37. Is the direct quantitation of antibiotics in agar by high-performance liquid chromatography useful?
    Arcelloni C; Vaiani R; Paroni R
    J Chromatogr A; 1998 Jul; 812(1-2):111-6. PubMed ID: 9691312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The emergence of resistance of Pseudomonas aeruginosa in patients treated with ceftazidime.
    Foord RD; Butcher ME; Williams AH
    Scand J Infect Dis; 1987; 19(1):143. PubMed ID: 3105046
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro interactions of gamma-linolenic acid and arachidonic acid with ceftazidime on multiresistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Grecka P; Dionyssiou-Asteriou A; Giamarellou H
    Lipids; 1999; 34 Suppl():S151-2. PubMed ID: 10419130
    [No Abstract]   [Full Text] [Related]  

  • 40. Ceftazidime resistance in Pseudomonas aeruginosa: transduction by a wild-type phage.
    Seginková Z; Krcméry V; Knothe H
    J Infect Dis; 1986 Dec; 154(6):1049-50. PubMed ID: 3097161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.